Growth Metrics

Astrana Health (ASTH) Amortization of Deferred Charges (2019 - 2025)

Astrana Health's Amortization of Deferred Charges history spans 11 years, with the latest figure at $1.2 million for Q3 2025.

  • For Q3 2025, Amortization of Deferred Charges rose 152.08% year-over-year to $1.2 million; the TTM value through Sep 2025 reached $3.3 million, up 94.08%, while the annual FY2024 figure was $1.8 million, 72.29% up from the prior year.
  • Amortization of Deferred Charges for Q3 2025 was $1.2 million at Astrana Health, up from $1.0 million in the prior quarter.
  • Across five years, Amortization of Deferred Charges topped out at $1.2 million in Q3 2025 and bottomed at $159000.0 in Q3 2021.
  • The 5-year median for Amortization of Deferred Charges is $350000.0 (2023), against an average of $410421.1.
  • The largest annual shift saw Amortization of Deferred Charges tumbled 54.05% in 2021 before it surged 152.08% in 2025.
  • A 5-year view of Amortization of Deferred Charges shows it stood at $178000.0 in 2021, then surged by 32.58% to $236000.0 in 2022, then surged by 48.31% to $350000.0 in 2023, then increased by 29.71% to $454000.0 in 2024, then surged by 153.74% to $1.2 million in 2025.
  • Per Business Quant, the three most recent readings for ASTH's Amortization of Deferred Charges are $1.2 million (Q3 2025), $1.0 million (Q2 2025), and $691000.0 (Q1 2025).